Battalora M S, Johnston D A, DiGiovanni J
Department of Carcinogenesis, University of Texas, M.D. Anderson Cancer Center, Smithville 78957, USA.
Cancer Lett. 1995 Nov 27;98(1):19-25.
The present study investigated a possible role for Ca2+ in skin tumor promotion by anthrones. This was accomplished by testing the effects of two Ca2+ antagonists, verapamil and 3,4,5-trimethoxybenzoic acid 8-(diethylamino) octyl ester (TMB-8), on tumor promotion and promoter-related effects induced by the anthrone chrysarobin in SENCAR mice. Verapamil and TMB-8 both effectively inhibited epidermal ornithine decarboxylase (ODC) induction by a single application of chrysarobin. Both Ca2+ antagonists inhibited anthrone-induced skin edema and epidermal hyperplasia. Additionally, both verapamil and TMB-8 slightly inhibited (20-21% at the highest doses) tumor promotion with chrysarobin. Although the inhibition by both Ca2+ antagonists was not statistically significant (P > 0.05) in either case, the fact that both compounds produced a similar inhibition suggests that this effect may be biologically relevant. Collectively, the data suggest a possible role for Ca2+ in the process of skin tumor promotion by anthrones.
本研究调查了Ca2+在蒽酮促进皮肤肿瘤过程中可能发挥的作用。通过测试两种Ca2+拮抗剂维拉帕米和3,4,5-三甲氧基苯甲酸8-(二乙氨基)辛酯(TMB-8)对蒽酮柯桠素诱导的SENCAR小鼠肿瘤促进作用及启动子相关效应的影响来实现这一目的。维拉帕米和TMB-8均能有效抑制单次应用柯桠素引起的表皮鸟氨酸脱羧酶(ODC)诱导。两种Ca2+拮抗剂均能抑制蒽酮诱导的皮肤水肿和表皮增生。此外,维拉帕米和TMB-8均能轻微抑制(最高剂量时为20-21%)柯桠素的肿瘤促进作用。尽管在这两种情况下,两种Ca2+拮抗剂的抑制作用均无统计学意义(P>0.05),但两种化合物产生相似抑制作用这一事实表明该效应可能具有生物学相关性。总体而言,数据表明Ca2+在蒽酮促进皮肤肿瘤的过程中可能发挥作用。